Literature DB >> 18281592

NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet.

Yuji Tanaka1, Lauren M Aleksunes, Ronnie L Yeager, Maxwell A Gyamfi, Noriko Esterly, Grace L Guo, Curtis D Klaassen.   

Abstract

NF-E2-related factor 2 (Nrf2) is a transcription factor that is activated by oxidative stress and electrophiles that regulates the expression of numerous detoxifying and antioxidant genes. Previous studies have shown that Nrf2 protects the liver from xenobiotic toxicity; however, whether Nrf2 plays a role in lipid homeostasis in liver is not known. Accordingly, wild-type and Nrf2-null mice were fed a high-fat diet (HFD) for up to 4 weeks. Hepatic gene expression and lipid profiles were analyzed for changes in fatty acid, triglyceride, and cholesterol status. It is interesting to note that HFD reduced the mRNA expression of Nrf2 and its target genes in wild-type mice. The mRNA expression of lipogenic and cholesterologenic transcriptional factors and their target genes, such as sterol regulatory element-binding proteins 1c and 2, fatty acid synthase, acetyl-CoA carboxylase 1, fatty acid elongase, 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase, and low-density lipoprotein receptor mRNA expression were higher in Nrf2-null mice compared with wild-type mice after feeding a HFD, suggesting that Nrf2 may suppress these pathways. Hepatic triglycerides and cholesterol levels were not different between genotypes, whereas concentrations of hepatic free fatty acid and malondialdehyde equivalents were higher in Nrf2-null mice compared with wild-type mice 4 weeks after HFD feeding. Overall, these results suggest that Nrf2 inhibits lipid accumulation and oxidative stress in mouse liver after feeding a HFD, probably by interfering with lipogenic and cholesterologenic pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281592     DOI: 10.1124/jpet.107.135822

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  100 in total

1.  Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.

Authors:  Anisha A Gupte; Joey Z Liu; Yuelan Ren; Laurie J Minze; Jessica R Wiles; Alan R Collins; Christopher J Lyon; Domenico Pratico; Milton J Finegold; Stephen T Wong; Paul Webb; John D Baxter; David D Moore; Willa A Hsueh
Journal:  Hepatology       Date:  2010-10-11       Impact factor: 17.425

Review 2.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

3.  Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity.

Authors:  Krisstonia Spruiell; Afua A Gyamfi; Susan T Yeyeodu; Ricardo M Richardson; Frank J Gonzalez; Maxwell A Gyamfi
Journal:  J Pharmacol Exp Ther       Date:  2015-07-09       Impact factor: 4.030

4.  Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.

Authors:  Yu-Kun Jennifer Zhang; Ronnie L Yeager; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-27       Impact factor: 4.219

Review 5.  Formation and signaling actions of electrophilic lipids.

Authors:  Francisco J Schopfer; Chiara Cipollina; Bruce A Freeman
Journal:  Chem Rev       Date:  2011-09-20       Impact factor: 60.622

6.  Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.

Authors:  James P Luyendyk; Bradley P Sullivan; Grace L Guo; Ruipeng Wang
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

8.  Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.

Authors:  Lauren M Aleksunes; Scott A Reisman; Ronnie L Yeager; Michael J Goedken; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2010-01-19       Impact factor: 4.030

9.  Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity.

Authors:  Jingbo Pi; Laura Leung; Peng Xue; Weiping Wang; Yongyong Hou; Dianxin Liu; Einav Yehuda-Shnaidman; Candy Lee; Jackie Lau; Theodore W Kurtz; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

10.  Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Authors:  Karen M Kassel; Bradley P Sullivan; Wei Cui; Bryan L Copple; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-07-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.